(Rac)-Tivantinib is the isomer of Tivantinib , and can be used as an experimental control. Tivantinib is a highly selective c-Met tyrosine kinase inhibitor with a Ki of 355 nM.
References:
[1]. Bai YL, et al. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatograp with tandem mass spectrometry. J Pharm Biomed Anal. 2016 Jul 15;126:98-102.
[2]. Munshi N, et al. ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. Mol Cancer Ther. 2010 Jun;9(6):1544-53.